Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.

Also called NCT01186120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01186120
Other papers using this trial's data
  • Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial Circulation. Cardiovascular interventions, 2014-06 DOI, PubMed 24823426

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01186120. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
Acronym
LONG-DES-V
Intervention (Device)
Biolimus A9-eluting stent
Intervention (Device)
Everolimus-eluting stent
Lead sponsor
Seung-Jung Park (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct01186120
Content hash
e0cf9795d46b92705fb204645f1f7e50570169d7384ff9e865635dc53b4ce776